Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Articles published by aTyr Pharma, Inc.
aTyr Pharma to Participate in April Investor Conferences
April 01, 2024
From
aTyr Pharma, Inc.
Via
GlobeNewswire
Tickers
LIFE
aTyr Pharma Announces Fourth Quarter and Full Year 2023 Results and Provides Corporate Update
March 14, 2024
From
aTyr Pharma, Inc.
Via
GlobeNewswire
Tickers
LIFE
aTyr Pharma to Webcast Conference Call Reporting Fourth Quarter and Full Year End 2023 Financial Results
February 28, 2024
From
aTyr Pharma, Inc.
Via
GlobeNewswire
Tickers
LIFE
aTyr Pharma Announces Expanded Access Program (EAP) for EFZO-FIT™ Clinical Trial Participants
February 21, 2024
From
aTyr Pharma, Inc.
Via
GlobeNewswire
Tickers
LIFE
aTyr Pharma to Present Posters Highlighting Importance of Neuropilin-2 in Immune Regulation at Keystone Symposia on Myeloid Cell Diversity
January 29, 2024
From
aTyr Pharma, Inc.
Via
GlobeNewswire
Tickers
LIFE
aTyr Pharma Announces Howard University President Emeritus Dr. Wayne A. I. Frederick as Advisor
January 18, 2024
From
aTyr Pharma, Inc.
Via
GlobeNewswire
Tickers
LIFE
aTyr Pharma to Present at November Investor Conferences
November 01, 2023
From
aTyr Pharma, Inc.
Via
GlobeNewswire
Tickers
LIFE
aTyr Pharma Announces Dosing of First Patient in Phase 2 EFZO-CONNECT™ Study of Efzofitimod in Patients with SSc-ILD
October 31, 2023
From
aTyr Pharma, Inc.
Via
GlobeNewswire
Tickers
LIFE
aTyr Pharma Presents Efzofitimod Data Demonstrating Statistically Significant Improvements in Time to Relapse, FVC and Patient Reported Outcomes
September 11, 2023
From
aTyr Pharma, Inc.
Via
GlobeNewswire
Tickers
LIFE
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.